Noninvasix Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • PIPE
  • (In Progress)

  • Latest Deal Amount
  • $3M

  • Investors
  • 18

Noninvasix General Information

Description

Developer of an optoacoustic platform technology designed to non-invasively and continuously measure central venous saturation. The company's technology specializes in monitoring the severity of sepsis and septic shock non-invasively to diagnose and monitor the response to treatment of tissue hypoxia in real-time, enabling clinicians to more quickly and accurately diagnose critically ill patients and tailor treatments to improve outcomes.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 301 University Boulevard
  • Galveston, TX 77555
  • United States
+1 (409)
Primary Industry
Monitoring Equipment
Other Industries
Other Healthcare Technology Systems
Vertical(s)
Corporate Office
  • 301 University Boulevard
  • Galveston, TX 77555
  • United States
+1 (409)

Noninvasix Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Noninvasix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
18. PIPE 31-Oct-2025 $3M In Progress Generating Revenue
17. Reverse Merger 31-Oct-2025 Announced Generating Revenue
16. Later Stage VC 03-Jul-2024 Completed Generating Revenue
15. Later Stage VC (Series A) 24-Apr-2023 Completed Pre-Clinical Trials
14. Accelerator/Incubator 01-Jan-2023 Completed Pre-Clinical Trials
13. Later Stage VC 06-May-2022 Completed Pre-Clinical Trials
12. Seed Round 18-Feb-2021 Completed Product Development
11. Seed Round 10-Jun-2020 Completed Product Development
10. Angel (individual) 07-Jan-2019 Completed Startup
9. Grant 05-Aug-2018 $180K Completed Startup
To view Noninvasix’s complete valuation and funding history, request access »

Noninvasix Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed 3
Seed 2
Seed 1 332,618 $0.001000 $1.02 $1.02 1x $1.02 3.4%
Seed 1,716,051 $0.001000 $1.22 $1.22 1x $1.22 17.53%
To view Noninvasix’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Noninvasix Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an optoacoustic platform technology designed to non-invasively and continuously measure central venous satu
Monitoring Equipment
Galveston, TX
3 As of 2026

San Clemente, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Noninvasix Competitors (1)

One of Noninvasix’s competitors is ICU Medical, a Corporation company based in San Clemente, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ICU Medical Corporation San Clemente, CA
You’re viewing 1 of 1 competitors. Get the full list »

Noninvasix Patents

Noninvasix Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026107206-A1 Methods and systems for melanin absorption-compensated blood oxygen Pending 15-Nov-2024
EP-4355219-A1 Sequential adaptor for combined ultrasound and optoacoustic diagnostic interrogation of the left innominate vein Inactive 16-Jun-2021
EP-4355219-A4 Sequential adaptor for combined ultrasound and optoacoustic diagnostic interrogation of the left innominate vein Inactive 16-Jun-2021
US-20240130709-A1 Sequential adaptor for combined ultrasound and optoacoustic diagnostic interrogation of the left innominate vein Pending 16-Jun-2021
WO-2022266250-A1 Sequential adaptor for combined ultrasound and optoacoustic diagnostic interrogation of the left innominate vein Inactive 16-Jun-2021 A61B8/4444
To view Noninvasix’s complete patent history, request access »

Noninvasix Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Noninvasix Investors (18)

Investor Name Investor Type Holding Investor Since Participating Rounds
Rockies Venture Club Venture Capital
Southwest National Pediatric Device Innovation Consortium Accelerator/Incubator
Cowtown Angels Angel Group Minority
Philips Corporation Minority
Green Park & Golf Ventures Venture Capital Minority
You’re viewing 5 of 18 investors. Get the full list »

Noninvasix Acquisitions (1)

Noninvasix’s most recent deal was a Merger/Acquisition with Cypher Metaverse. The deal was made on 12-Dec-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Cypher Metaverse 12-Dec-2025 Merger/Acquisition Private Equity
To view Noninvasix’s complete acquisitions history, request access »

Noninvasix FAQs

  • When was Noninvasix founded?

    Noninvasix was founded in 2007.

  • Where is Noninvasix headquartered?

    Noninvasix is headquartered in Galveston, TX.

  • What is the size of Noninvasix?

    Noninvasix has 3 total employees.

  • What industry is Noninvasix in?

    Noninvasix’s primary industry is Monitoring Equipment.

  • Is Noninvasix a private or public company?

    Noninvasix is a Private company.

  • What is Noninvasix’s current revenue?

    The current revenue for Noninvasix is .

  • How much funding has Noninvasix raised over time?

    Noninvasix has raised $10.1M.

  • Who are Noninvasix’s investors?

    Rockies Venture Club, Southwest National Pediatric Device Innovation Consortium, Cowtown Angels, Philips, and Green Park & Golf Ventures are 5 of 18 investors who have invested in Noninvasix.

  • Who are Noninvasix’s competitors?

    ICU Medical is a competitor of Noninvasix.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process